Frigate Ventures »

Intercept Pharmaceuticals In Note 2.000 5/1 bnd shares owned by Frigate Ventures

Quarter-by-quarter ownership of Intercept Pharmaceuticals In Note 2.000 5/1 bnd shares owned by Frigate Ventures from 13F filings

Historical chart of Frigate Ventures investment in Intercept Pharmaceuticals In Note 2.000 5/1 bnd

Tip: Access up to 7 years of quarterly data

All positions including Intercept Pharmaceuticals In Note 2.000 5/1 bnd held by Frigate Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intercept Pharmaceuticals In Note 2.000 5/1 bnd by Frigate Ventures

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.9M 4.0M 0.98

More positions owned by Frigate Ventures

Tempur Sealy International Equity (TPX)
AdvisorShares Pure US Cannabis ETF Exchange Traded Fund (MSOS)
Nano Dimension Adr (NNDM)
Blockchain Coinvestors Acquisition Corp I Warrant (BCSAW)
iShares U.S. Real Estate ETF Exchange Traded Fund (IYR)
iShares 20 Year Treasury Bond ETF Option Call Option (TLT)
SPDR S&P 500 ETF Trust Option Put Option (SPY)
iShares iBoxx High Yield Corporate Bond ETF Option Put Option (HYG)
Block Option Call Option (SQ)
Activision Blizzard Equity
Oncolytics Biotech Equity (ONCY)
Vivid Seats Equity (SEAT)
iShares China Large-Cap ETF Option Call Option (FXI)
Invesco QQQ Trust Series 1 Option Put Option (QQQ)
Tricon Residential Option Call Option (TCN)

View all positions for Frigate Ventures

Top funds holding Intercept Pharmaceuticals In Note 2.000 5/1 bnd

Ubs Global Asset Management Americas

View all funds holding Intercept Pharmaceuticals In Note 2.000 5/1 bnd